Sequence Variants of Peroxisome Proliferator-Activated Receptor-Gamma Gene and the Clinical Courses of Patients with End-Stage Renal Disease

Table 3

Genotype distributions of the study population by cases with DM, cases without DM, and control status.

Variables	Controls	Cases_non-DM	Cases_DM
Number of subjects	782	512	186
PPAR-γ Pro12Ala genotype				0.027
CC	735 (94.0%)	471 (92.0%)	164 (88.2%)
CG	46 (5.9%)	37 (7.2%)	21 (11.3%)
GG	1 (0.1%)	4 (0.8%)	1 (0.5%)
PPAR-γ C161T genotype				0.673
CC	451 (57.7%)	278 (54.3%)	106 (57.0%)
CT	283 (36.2%)	198 (38.7%)	65 (34.9%)
TT	48 (6.1%)	36 (7.0%)	15 (8.1%)

 ^*Continuous variables were tested by Mann-Whitney tests, whereas categorical variables were tested by chi-square test or Fisher’s exact test.